Search
Olokizumab
go.drugbank.com/drugs/DB13127InvestigationalTargeting IL-6 function can be achieved directly, or through interrupting the IL-6 receptor or gp130 receptor axes.
NasoVAX
go.drugbank.com/drugs/DB15859InvestigationalCreated by Altimmune, Inc., NasoVAX is currently being developed for seasonal and pandemic use as it can activate humoral and cellular immune responses. … As of June 2020, NasoVAX is being evaluated in a Phase 2 clinical trial for safety and effectivness in preventing worsening symptoms in hospitalized COVID-19 patients (NCT04442230).
Gantenerumab
go.drugbank.com/drugs/DB12034InvestigationalDespite the clear association of Aβ aggregation with AD, treatments aimed at preventing Aβ aggregation or removing pre-existing Aβ plaques have shown little to no clinical benefit thus far and remain controversial
Idrocilamide
go.drugbank.com/drugs/DB13297ExperimentalCategories: Topical Products for Joint and Muscular PainTibezonium iodide
go.drugbank.com/drugs/DB13702ExperimentalCategories: Antiinfectives and Antiseptics for Local Oral TreatmentEfmarodocokin alfa
go.drugbank.com/drugs/DB16398InvestigationalEfmarodocokin alfa is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).
Clomethiazole
go.drugbank.com/drugs/DB06470InvestigationalIt is also used for the management of agitation, restlessness, short-term insomnia and Parkinson's disease in the elderly.
Mito-4509
go.drugbank.com/drugs/DB05846ExperimentalMito-4509 is a non-feminizing estrogen analog that could affect mitochondrial metabolic pathways. It is used to treat Parkinson's Disease, Alzheimer's Disease, Retinal Disorders and other neurologic Disorders.
Trafermin
go.drugbank.com/drugs/DB06244InvestigationalCategories: Preparations for Treatment of Wounds and Ulcers